MicroPort NeuroScientific Corporation (02172.HK)

MicroPort NeuroScientific Corp. engages in the business of research and development, manufacturing, and selling neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 522 full-time employees. The company went IPO on 2022-07-15. The products cover three areas of cerebrovascular disease, including hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The hemorrhagic stroke products mainly include NUMEN coil, NUMEN Silk three dimensional (3D) electronically detachable coil, Nufairy absorbable embolization coil and Tubridge flow-diverting stent. The intracranial atherosclerotic stenosis products mainly include APOLLO intracranial stent, Bridge vertebral artery drug-eluting stent (DES) and Diveer intracranial balloon dilatation catheter. The acute ischemic stroke products mainly include Neurohawk intracranial thrombectomy device, Tigertriever revascularization stent and WAVE-track intracranial aspiration catheter. The products also include auxiliary access devices such as Fastrack microcatheter and U-track intracranial support catheter.